A rare case of autoimmune limbic encephalitis: an uncharted territory!

References

1. ↵
   1. Graus F,
   2. Saiz A,
   3. Dalmau J

   (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257, 509–517.
2. ↵
   1. Lancaster E,
   2. Martinez-Hernandez E,
   3. Dalmau J

   (2011) Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 77, 179–189.
3. ↵
   1. Montojo MT,
   2. Petit-Pedrol M,
   3. Graus F,
   4. Dalmau J

   (2015) Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex. Neurologia 30, 295–301.
4. ↵
   1. Lai M,
   2. Huijbers MG,
   3. Lancaster E,
   4. Graus F,
   5. Bataller L,
   6. Balice-Gordon R,
   7. et al.

   (2010) InInvestigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9, 776–785.
5. ↵
   1. Lancaster E,
   2. Huijbers MG,
   3. Bar V,
   4. Boronat A,
   5. Wong A,
   6. Martinez-Hernandez E,
   7. et al.

   (2011) Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69, 303–311.
6. ↵
   1. Fukata Y,
   2. Lovero KL,
   3. Iwanaga T,
   4. Watanabe A,
   5. Yokoi N,
   6. Tabuchi K,
   7. et al.

   (2010) Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci U S A 107, 3799–3804.
7. ↵
   1. Gregor A,
   2. Albrecht B,
   3. Bader I,
   4. Bijlsma EK,
   5. Ekici AB,
   6. Engels H,
   7. et al.

   (2011) Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1. BMC Med Genet 12, 106.
8. ↵
   1. Vincent A,
   2. Buckley C,
   3. Schott JM,
   4. Baker I,
   5. Dewar BK,
   6. Detert N,
   7. et al.

   (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127, 701–712.
9. ↵
   1. Irani SR,
   2. Stagg CJ,
   3. Schott JM,
   4. Rosenthal CR,
   5. Schneider SA,
   6. Pettingill P,
   7. et al.

   (2013) Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 136, 3151–3162.